Winningham Rick E sold TBPH
February 20, 2026 · Form 4 insider transaction
Winningham Rick E sold 74,975 shares of Theravance Biopharma Inc at $19.66 per share, a transaction worth $1.47M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
74,975
Price
$19.66
Total value
$1.47M
InsiderWinningham Rick E
RoleOfficer, Director
SecurityOrdinary Shares
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 20, 2026
Filing dateFebruary 24, 2026
Shares owned after1,576,094
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.